glp 3 peptide vs glp 1 Retatrutide Semaglutide and Tirzepatide: GLP-3 Facts explained TrimRX | GLP-1 vs GIP:
Description
Matt Budoff on a one-year CT-angiography study of lean, keto-adhering hyper-responders with very high LDL/ApoB
More recently, a CVOT compared tirzepatide with dulaglutide in people with type 2 diabetes and CVD
This isn't a controversial point in pharmacology
This change may reduce infrastructure complexity and associated costs for manufacturers whose internal capabilities include fill-finish operations
Worth watching if you prefer hearing a physician walk through the rationale rather than reading it
Several GLP-1 receptor agonists are currently licensed for use in the UK, including semaglutide (Ozempic, Wegovy, Rybelsus), dulaglutide (Trulicity), liraglutide (Victoza, Saxenda), exenatide (Bydureon BCise), and lixisenatide (Lyxumia)
